This inventor holds 1 USPTO granted patent. Top assignees: Association Pour L'essor De La Transfusion Sanguine Dans La Region Du, Biotest Pharma Gmbh. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Herve Broly: Innovator in Monoclonal Antibodies
Introduction
Herve Broly is a notable inventor based in Perenchies, France. He has made significant contributions to the field of immunology, particularly in the development of human monoclonal antibodies.
Latest Patents
Herve Broly holds a patent for "Human monoclonal anti-rhesus (D) antibodies and cell lines producing same." This invention relates to two human monoclonal antibodies of subclasses IgG1 and IgG3, which target the Rhesus D antigen. The patent also includes a pharmaceutical composition designed for the prophylaxis of hemolytic disease of the newborn. Additionally, the invention encompasses heterohybridoma cell lines that produce these antibodies, which are filed with the Deutsche Sammlung von Mikroorganismen und Zellkulturen under accession numbers DSM AC 2039 and DSM AC 2040. He has 1 patent to his name.
Career Highlights
Throughout his career, Herve Broly has worked with various organizations, including the Association Pour L'Essor De La Transfusion Sanguine Dans La Region Du and Biotest Pharma GmbH. His work has significantly impacted the field of transfusion medicine and immunology.
Collaborations
Herve Broly has collaborated with notable professionals in his field, including Roland Beliard and Michael Kloft. These collaborations have contributed to the advancement of research and development in monoclonal antibodies.
Conclusion
Herve Broly's innovative work in the development of human monoclonal antibodies has made a lasting impact on medical science. His contributions continue to influence the field of immunology and the treatment of hemolytic disease of the newborn.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile